Clinical Trials
71 trialsFORWARD
CareDx
Real World Asparaginase Therapy Toxicity
St. Jude Children's Research Hospital
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Novartis
Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)
University of Utah
QiNKT-HSCT
University Hospital Pilsen
ENKLA-M
Nantes University Hospital
Plasma Host-Microbe Proteomics to Predict Complications in High-risk Febrile Neutropenia
Instituto de Investigación Biomédica de Salamanca
LANA
Nantes University Hospital
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
Washington University School of Medicine
TITLE CLL
The Royal Wolverhampton Hospitals NHS Trust
The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt
Assiut University
Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration
Mayo Clinic
CHIS
Assistance Publique - Hôpitaux de Paris
CIRCALL
Assistance Publique - Hôpitaux de Paris
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
The Children's Hospital of Zhejiang University School of Medicine
Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients
Assiut University
PONA4ALL Ph+
Gruppo Italiano Malattie EMatologiche dell'Adulto
Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .
Assiut University
Adoption of Audio Recording in the Outpatient Supportive Care Center
M.D. Anderson Cancer Center
Reticulocyte Parameters as Early Indicators of Bone Marrow Erythropoietic Activity in Chronic B Lymphoproliferative Neoplasms
Assiut University
QOL-ONE PRO-CT
Associazione Qol-one
NEO-COAG
University Hospital, Strasbourg, France
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
ARCE Therapeutics, Inc.
DUALFLOW
University Hospital, Bordeaux
What is the Impact of TKI on Thyroid Function in CML Patients?
Assiut University
Clinico-hematological and Molecular Characteristics of Chronic Lymphocytic Leukemia Patients
Assiut University
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Sohag University
DOREMy
Assistance Publique - Hôpitaux de Paris
Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
Assiut University
AML/BMI
Assiut University
succinylation
The First Affiliated Hospital of Xinxiang Medical College
The Kinetics Profiling of Immune Reconstitution and Clinical Outcomes
Peking University People's Hospital
The Prognostic Significance of Platelet to White Blood Cell Ratio (PWR) in Patients With Acute Myeloid Leukemia
Assiut University
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia
Assiut University
ABO and Rh Blood Group Frequencies in Acute Leukemia Patients
Assiut University
ASC4REAL-2
Novartis
ACTIVATE
Gruppo Italiano Malattie EMatologiche dell'Adulto
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
Peking University First Hospital
LAMSA
Assistance Publique - Hôpitaux de Paris
Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid Leukemia
Assiut University
FUTURE
Assistance Publique Hopitaux De Marseille
EPIAMLINF
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
BEACON
University of Southampton
ERAPH
University Hospital, Montpellier
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
National Research Center for Hematology, Russia
Using a Population Pharmacokinetic Model to Estimate the Dosage of Teicoplanin in Patients With Hematologic Malignancy or Critical Illness
National Taiwan University Hospital
Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic Leukemia
Assiut University
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
Shandong University